FDA approves new eczema drug Dupixent
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis).
Monthly Archives: March 2017
Skin diseases: List of common conditions and symptoms
In this article, learn about permanent skin diseases, temporary skin diseases, internal skin diseases, and skin diseases for different age groups.
Severe psoriasis predominantly affects men
The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men.
Bumps on the skin: Pictures, causes, and treatments
Learn all about common types of bumps found on the skin, from skin tags to melanomas, including their causes, treatment options, and when to see a doctor.
Common skin rashes: Pictures, causes, and treatments
In this article, we look at a variety of skin rashes including eczema, hives, and psoriasis. Learn about possible triggers and when to see a doctor.
Six fixes for cracked heels
In this article, learn about the common causes of cracked heels, how cracked heels may be prevented, and home remedies that are recommended.
FDA approves first treatment for rare form of skin cancer
The U.S. Food and Drug Administration has granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell...
HIV lesions: Pictures and treatments
People with HIV can be prone to skin lesions. In this article, we take a close look at the causes and treatments available for the most common types.
Oral and topical antibiotics for clinically infected eczema in children: A pragmatic randomized controlled trial in ambulatory care
Estimates suggest that 40 percent of eczema flares are treated with topical antibiotics, but findings from this study published in Annals of Family Medicine suggest there is no meaningful benefit...
Why do shorter men go bald more often?
Short men may have an increased risk of becoming bald prematurely. An international genetic study under the leadership of the University of Bonn at least points in this direction.